Arvest Trust »

Alnylam Pharmaceuticals shares owned by Arvest Trust

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Arvest Trust from 13F filings

Historical chart of Arvest Trust investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Arvest Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Arvest Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $215k 472 456.00

More positions owned by Arvest Trust

Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
New World CL R-6
Goldman Sachs Etf Tr Activebeta Eme (GEM)
NVIDIA Corporation (NVDA)
Tortoise Capital Series Trus North Amern Pipe (TPYP)
Apple (AAPL)
Wal-Mart Stores (WMT)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Arvest Trust

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals